Description

BSE revokes the suspension of trading in equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373), allowing resumption of trading activities.

Summary

BSE has revoked the suspension in trading of equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373, ISIN: INE795B01031). The company profile document provides comprehensive details about the company’s operations, management, and compliance status as part of the revocation process.

Key Points

  • Trading suspension has been revoked for Citurgia Biochemicals Limited
  • Scrip Code: 506373
  • ISIN: INE795B01031
  • Company engaged in manufacturing, processing, and dealing in citric acid
  • Registered office located in Mumbai, Maharashtra
  • Plant location at Virbhadra Road, Rishikesh, Uttarakhand
  • Listed only on BSE Limited
  • Current auditor: G.P. Keshri & Associates (appointed for FY 2022-2027)
  • Company is in process of appointing a Company Secretary & Compliance Officer

Company Leadership

Managing Director & Chairman: Mr. Kashi Nath Jha (DIN: 02072952)

Board of Directors:

  • Mr. Vivek Singh
  • Ms. Reena Devi Mandal
  • Mr. Subhash Sahu
  • Mr. Kashi Nath Jha
  • Mr. Dharmendra
  • Mr. Jitendra Prasad

Compliance Requirements

  • Company has paid listing fees to BSE
  • No action taken by any other exchange in last five years
  • Company maintains active operational status
  • Auditor appointment valid through March 31, 2027
  • Company Secretary & Compliance Officer position currently vacant and under recruitment

Important Dates

  • Document Date: November 7, 2025
  • Circular Publication Date: January 30, 2026
  • Auditor Term: April 1, 2022 to March 31, 2027

Impact Assessment

Market Impact: High - The revocation of trading suspension restores market liquidity for shareholders and enables price discovery for the security. Investors who were unable to exit or enter positions during suspension can now trade freely.

Operational Impact: The company’s ability to access capital markets is restored, improving its financial flexibility. The revocation indicates the company has addressed compliance issues or concerns that led to the original suspension.

Compliance Status: Company demonstrates compliance with listing requirements by maintaining updated disclosures, paying listing fees, and providing comprehensive company profile information. However, the absence of a Company Secretary & Compliance Officer is a gap that needs to be addressed.

Impact Justification

Revocation of trading suspension directly impacts investors' ability to trade shares and company's market liquidity